We are a biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Our secondary operations are focused on establishing anti-depression clinics across the United Kingdom and providing business support services to similar entities in the United States and using psychiatric assessment combined with physician/medical providers to administer intravenous infusions of ketamine.
Sector:
Healthcare
Industry:
Pharmaceutical and Medicine Manufacturing
Investor Relations
In-Site Communications, Inc
Lisa Carlton-Wilson
Founder
T: 917-543-9932
lwilson@insitecony.com
Company Contact
Pasithea Therapeutics Corp.
1111 Lincoln Road
Suite 500
Miami Beach, FL 33139
T: 305-493-8080
info@pasithea.com